Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation?

Thrombosis Research
Paul Monagle

Abstract

Since Maureen Andrew began systematically describing thrombosis in children in 1994, there has been surprisingly slow process in advancing our knowledge in terms of diagnosis, prevention and treatment of thrombosis in children. There are a variety of reasons for this slow progress. Overwhelmingly the low incidence of thrombosis in children has been a major barrier. Second, the developmental, age related, changes in haemostasis mean that the physiology of haemostasis in children, and the interaction of the haemostatic system with anticoagulant drugs is constantly changing. This presents further challenges in identifying the risk benefit ratio of therapies. In addition, the failure to adequately understand the subtleties of pathogenesis of the variety of thrombotic syndromes, and the failure to know the natural history of many types of thrombosis are also significant problems. We continue to try and solve these problems by extrapolation, not just of adult based data, but of methodologies for research founded in the adult paradigm. If we are truly going to improve our understanding of thrombosis in children and improve our ability to prevent and adequately treat thrombosis in this population, then we need multiple paradigm shifts;...Continue Reading

Citations

Jan 10, 2020·Blood·Char Witmer, Leslie Raffini
Oct 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Victoria RobinsonElisabeth T Tracy
Apr 2, 2021·Journal of Thrombosis and Haemostasis : JTH·C Heleen van OmmenUNKNOWN Subcommittee on Pediatric, Neonatal Thrombosis, Hemostasis
Jul 4, 2021·Emergency Medicine Clinics of North America·Kathleen Stephanos, Sarah B Dubbs
Mar 22, 2020·Pediatrics·Brian S Donahue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

International Journal of Laboratory Hematology
P Toulon
Seminars in Thrombosis and Hemostasis
Daniela TormenePaolo Simioni
Thrombosis Et Diathesis Haemorrhagica. Supplementum
E F Lüscher
© 2022 Meta ULC. All rights reserved